Announcement
Super Grannies and Market Update – June 30 Webinar Cancelled

Major Study Points to COVID-19 Treatment; ‘Game Changer?”

COVID-19 remains a global crisis, particularly since we are moving into the more critical stage ("restart economy"), so please feel free to share this with anyone interested. Last evening, the world learned a Univ. of Chicago's Phase 3 trial of Gilead's (GILD) Remdesivir shows significant promise.
Remdesivir has been talked about for some time so I understand the skepticism, but the market has jumped 3% at the prospect.

Policymakers say a vaccine is key, but that could be six to 18 months away so ...

Finish reading this report for free

Enter your email and we’ll send the paywall-free link directly to your inbox

In addition to your unlocked report, you will receive our weekly market newsletter FSI Snapshot, as well as occasional updates and offers from FS Insight. You can unsubscribe at any time. For more information, see our privacy policy.

Get unlimited access to Tom Lee’s Fundstrat research Subscribe
Already a member? Log in

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In

Trending tickers in our research

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In